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Abstract 
Background: Zinc finger RNA binding protein (ZFR) is involved in the regulation of growth and cancer development. 
However, little is known about ZFR function in pancreatic cancer.
Methods: Herein, to investigate whether ZFR is involved in tumor growth, Oncomine microarray data was firstly used 
to evaluate ZFR gene expression in human pancreatic tumors. Then short hairpin RNA (shRNA) targeting ZFR was 
designed and delivered into PANC-1 pancreatic cancer cells to knock down ZFR expression. Cell viability, cell prolifera-
tion and cell cycle analysis after ZFR knockdown were determined by MTT, colony forming and FACS, respectively. In 
addition, cell migration and invasion were assessed using the Transwell system.
Results: The expression of ZFR was significantly higher in pancreatic tumors than normal pancreas tissues by 
Oncomine database analysis. Knockdown of ZFR by shRNA-expressing lentivirus significantly decreased the viability 
and invasion ability of pancreatic cancer cells. Moreover, FACS analysis showed that knockdown of ZFR in PANC-1 cells 
caused a significant cell cycle arrest at G0/G1 phase. Furthermore, knockdown of ZFR decreased the levels of CDK2, 
CDK4, CyclinA and CyclinD1 and enhanced the expression of p27, which has evidenced by qRT-PCR and Western blot 
analysis.
Conclusions: Knockdown of ZFR might provide a novel alternative to targeted therapy of pancreatic cancer and 
deserves further investigation.
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Background
Pancreatic cancer is currently the fourth most common 
cause of cancer-related mortality in USA [1], character-
ized by difficult diagnosis, distant metastasis and aggres-
sive local invasion at an early stage [2]. The five-year 
survival rate among patients with pancreatic cancer is 
less than 5 % [3, 4] and almost all the patients succumbed 
to their disease within 2 years [5]. In the last two decades, 
strategies including surgery, radiation and chemotherapy, 
have failed to improve long-term survival [6]. Recent 
efforts have focused on the application of novel targeted 
agents based on a better understanding of the mecha-
nisms involved in tumor progression.
Zinc finger proteins, encoded by zinc finger RNA bind-
ing (ZFR), has been reported to play an important role in 
DNA binding and regulate growth and development [7]. 
ZFR is an ancient and highly conserved chromosome-
associated protein from nematodes to mammals [8]. The 
murine ZFR protein was identified in a screen for RNA-
binding proteins expressed during spermatogenesis [9]. 
The human ZFR appears to be involved in the regulation 
of alternative pre-mRNA splicing [10] and was identified 
in a screen for factors that interact with the pre-mRNA 
splicing activator RNPS1 [11]. Transcript levels were 
determined for ZFR in various human tissues but unde-
tectable in skeletal muscle [10]. Knockdown expression 
of ZFR through RNA interference in neurons relocated 
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specifically the Staufen 2 (62), isoform to the nucleus, 
which suggest that ZFR is critical for Staufen 2 isoform 
specific nucleocytoplasmic shuttling in neurons and 
likely acts key function during early steps of RNA trans-
port and localization [12]. TDP-43 was shown to be a 
major disease protein in most cases of amyotrophic lat-
eral sclerosis (ALS), tau-negative frontotemporal lobar 
degeneration (FTLD), and inclusion body myopathy. 
Mass spectrometry identified ZFR as one of the TDP-
43 interacting proteins [13]. In addition, ZFR has been 
demonstrated to direct the targeted chromosomal inte-
gration of a plasmid at specific recognition sites distrib-
uted throughout human genomes in several cell types 
[14]. Despite recent obtained advances in understanding 
the biology function of ZFR, there is poor report about 
the effect of ZFR on pancreatic cancer diagnosis and 
prognosis.
In the present study, we aimed to investigate whether 
ZFR functions as potential target in pancreatic cancer, 
one stable knockdown of ZFR cell line model was con-
structed using lentivirus-mediated RNA interference 
technique. Based on constructed ZFR silencing cell 
model, we further determined the biological function 
of ZFR silencing on pancreatic cancer as well as down-
stream target proteins expression level.
Methods
Materials
Dulbecco’s modified Eagle’s medium (DMEM) 
was obtained from Hyclone (Catalog Number: 
SH30243.01B+, Logan, Utah, USA). Fetal bovine serum 
(FBS) was obtained from Biowest (Catalog Number: 
S1810, Loire Valley, France). The lentiviral expression 
vector (pFH-L) and packaging vectors (pVSVG-I and 
pCMVΔR8.92) were purchased from Hollybio (Shang-
hai, China). Lipofectamine 2000 and TRIzol® Reagent 
was purchased from Invitrogen (Carlsbad, CA, USA). 
M-MLV Reverse transcriptase was purchased from Pro-
mega (Madison, WI, USA). All other chemicals were 
obtained from Sigma-Aldrich (St. Louis, MO, USA).
Analysis of oncomine data
To determine the expression pattern of ZFR in pancre-
atic cancer, two datasets, including Badea Pancreas [15] 
and Segara Pancreas [16] in Oncomine database (www.
oncomine.org) were used. The gene expression of ZFR 
was compared between pancreatic cancer tissues with 
normal pancreatic tissues according to the standard pro-
cedures as previously described [17].
Cell culture
Human pancreatic cancer cell line, PANC-1 and human 
embryonic kidney cell line 293T were obtained from the 
Cell Bank of Chinese Academy of Science (Shanghai, 
China). Both cell lines were cultured in DMEM supple-
mented with 10 % FBS at 37 °C with 5 % CO2.
Construction of recombinant lentiviral vector
The cDNA sequence of ZFR was obtained from Gen 
Bank (NM_016107). The shRNA target sequence for 
ZFR was 5′-GCCAAGGTGCAACTCAGTATACTCG 
AGTATAC TGAGT TG C ACC T TG G C T T T T T-3 ′ , 
which was subjected to BLAST analysis against the 
human genome database to eliminate cross-silence phe-
nomena with nontarget genes. A scrambled fragment 
(5 ′ -G C G GAG G GT T TGA A AGA ATATC TC GAG 
ATATTCTTTCAAACCCTCCGCTTTTTT-3′) that has 
no significant homology with human gene sequences 
was used as a negative control. DNA oligonucleotides 
to produce plasmid-based shRNA were cloned into the 
pFH-L vector by use of NheI/PacI restriction sites. The 
lentiviral expression vector (pFH-L) and packaging vec-
tors (pVSVG-I and pCMVΔR8.92) were cotransfected 
into 293T cells with Lipofectamine 2000 according to 
the manufacturer’s instructions. The supernatant was 
collected 48 h later, centrifuged (4000g, 4 °C, 10 min) to 
remove cell debris, filtered through 0.45-μm cellulose 
acetate filters, and then concentrated again (4000g, 4 °C, 
15  min). The lentiviral vectors expressed green fluo-
rescence protein (GFP), which allowed for titering and 
measurement of their infection efficiency in transduced 
cells. PANC-1 cells were dispensed into 6-well plates at 
a density of 50,000 cells per well and transduced with 
shRNA-expressing lentivirus at a multiplicity of infection 
(MOI) of 75. GFP expression was observed by fluorescent 
microscopy 4 days post-transduction.
Quantitative real‑time polymerase chain reaction 
(qRT‑PCR)
Cells transduced with shRNA-expressing lentivirus 
were divided into two groups (shCon, shZFR). PANC-1 
cells were harvested after lentivirus transduction for 
6  days. Total cellular RNA was extracted using Trizol 
reagent and reversely transcripted to cDNA by M-MLV 
reverse transcriptase according to the manufacturer’s 
instructions. qRT-PCR products were detected with 
SYBR Green on BioRad Connect Real-Time PCR plat-
form following the procedure: denaturation at 95  °C 
for 1 min, 40 cycles of denaturation at 95 °C for 5 s and 
extension at 60  °C for 20  s. Specific cDNAs were then 
amplified by qRT-PCR using the following primers: 
ZFR, 5′-TCCCAATGCTAAGGAGATGC-3′ (forward) 
and 5′-TTCTTCTCGTCTTCGCCAGT-3′ (reverse); 
CDK2, 5′-TCCAGGATGTGACCAAGCC-3′ (forward) 
and 5′-CTGAGTCCAAATAGCCCAAGG-3′ (reverse); 
CyclinA, 5′-GTTCCTCCTTGGAAAGCAAAC-3′ (for-
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ward), 5′-GGGCATCTTCACGCTCTATTT-3′ (reverse); 
CyclinD1, 5′-GCCCTCGGTGTCCTACTTC-3′ (forward), 
5′-CCTCCTCGCACTTCTGTTCC-3′ (reverse); p27, 
5′-GCTACCCTTGACAAGAAAAGAC-3′ (forward), 5′-AA 
AGTATGCTTACTAAAGGTCCTG-3′ (reverse) and 
β-actin, 5′-GTGGACATCCGCAAAGAC-3′ (forward) 
and 5′-AAAGGGTGTAACGCAACTA-3′ (reverse). The 
β-actin was used as internal control. Relative quantitation 
was analyzed by taking the difference ΔC(T) between 
the C(T) of β-actin and C(T) of ZFR and computing 
2-ΔΔC(T) as described previously [18].
Western blot analysis
Cells transduced with shRNA-expressing lentivirus were 
divided into two groups (shCon, shZFR). PANC-1 cells 
were harvested after lentivirus transduction for 6  days. 
Total protein was extracted with 2 × SDS Sample Buffer 
[100  mM Tris–HCl (pH 6.8), 10  mM EDTA, 4  % SDS, 
10  % Glycine]. Total protein concentration was deter-
mined by BCA assay. Protein extracts were separated by 
10  % SDS-PAGE and transferred to PVDF membranes. 
The membranes were blocked with 5 % nonfat dry milk 
in Tris-buffered saline with Tween 20 (TBST) for 1 h at 
37 °C, and then incubated overnight at 4 °C in TBST with 
primary antibody, including rabbit anti-ZFR (1:1000, 
SAB2104153, sigma), mouse anti-CDK4 (1:500, #2906, 
cell signaling), rabbit anti-CDK2 (1:1000, #2546, cell 
signaling) and rabbit anti-GAPDH (1:100000, 10494-1-
AP, Santa cruz). Following incubation with horseradish 
peroxidase-conjugated goat anti-rabbit/mouse second-
ary antibody for 1 h, the membranes were detected using 
enhanced chemiluminescence (ECL) kit (Amersham) and 
visualized by exposure to X-ray film. GAPDH was used as 
a control to verify equal protein loading.
MTT assay
To detect cell viability, 3-(4, 5-dimethylthiazol-2-yl)-2, 
5-diphenyl-tetrazolium bromide (MTT) colorimetric 
assay was performed 4 days after lentivirus transduction. 
Briefly, PANC-1 cells were dispensed into 96-well plates 
at a density of 2000 per well. The plates were incubated 
for one to 5 days at 37 °C. On each day, 100 ml of MTT 
(5 mg/ml) was added and incubated for 4 h. Afterwards, 
the entire supernatant was discarded and acidic isopro-
panol (10 % SDS, 5 % isopropanol and 0.01 mol/L HCl) 
was added at a volume of 100 μl per well and incubated at 
37 °C for 10 min. The absorbance at 595 nm of each well 
was determined using an ELISA reader.
Colony formation assay
To detect cell proliferation, colony formation assay was 
performed 4  days after lentivirus transduction. Briefly, 
PANC-1 cells were dispensed into 6-well plates at a den-
sity of 500 per well. The culture medium was changed 
at three-day intervals. PANC-1 cells were cultured for 
10 days until the most single colony contains more than 
50 cells. The colonies were stained with crystal violet for 
15 min, and then washed with water and air-dried. Cell 
colonies were captured and counted under a microscope.
Fluorescence‑activated cell sorting analysis (FACS)
To detect cell cycle progression, flow cytometry assay 
was performed 7  days after lentivirus transduction as 
described previously [19]. Briefly, PANC-1 cells were dis-
pensed into 6-cm dishes at a density of 200,000 per dish. 
After culture at 37 °C for 40 h, cells were harvested, fixed 
in 70  % ethanol, and stored overnight at 4  °C. The cells 
were then treated with NaCl/Pi staining solution (50 µg/
mL PI and 100  µg/mL RNase A). Following incubation 
for 1 h in the dark at room temperature, cells were ana-
lyzed by flow cytometry (FACSCalibur; Becton–Dickin-
son, San Jose, CA, USA). The fractions of the cells in G0/
G1, S and G2/M phases were analyzed with dedicated 
software (Becton–Dickinson).
Cell migration and invasion assays
The migration and invasion ability of PANC-1 following 
ZFR knockdown were evaluated using Transwell (8 µm pore 
size, Millipore). Briefly, cells were suspended in serum-free 
medium and seeded into Transwell inserts either uncoated 
(for migration assay) or coated (for invasion assay) with 
growth factor-reduced Matrigel (BD Biosciences, Bedford, 
MA). Botton wells were filled with complete medium. Then 
the invaded cells were fixed with methanol and stained with 
a crystal violet solution. Finally, the number of migratory 
and invasive cells were counted in five fandom fields under a 
microscope at 200 × magnification.
Statistical analysis
Statistical analysis was performed using SPSS 13.0 soft-
ware package (SPSS Inc, Chicago, IL, USA). Data were 
expressed as mean ± standard deviation from three inde-
pendent experiments. Statistical differences between the 
groups were compared using Student’s t test. A P value of 
less than 0.05 was considered statistically significant.
Results
ZFR is upregulated in pancreatic cancer
ZFR mRNA levels in human pancreatic cancer tissues 
were investigated using two datasets from the publicly 
available oncomine database. As shown in Fig.  1, all of 
the two datasets showed a significantly higher level of 
ZFR expression in pancreatic cancer tissues compared 
with the normal pancreatic tissues (p < 0.01).
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Knockdown of endogenous ZFR by shRNA‑expressing 
lentivirus
PANC-1 cells were transduced with shRNA-expressing 
lentivirus (shCon: control group or shZFR: short hairpin 
Zinc finger RNA), respectively. The infection efficiency 
was confirmed by evaluating GFP expression levels. As 
depicted in Fig. 2a, over 80 % of cells infected with shZFR 
expressed GFP, which suggested that the lentivirus trans-
duction was successful and highly efficient. The effect of 
shZFR on ZFR expression in PANC-1 cells was investi-
gated by qPCR and western blot analysis. As depicted 
in Fig.  2b, the mRNA levels of ZFR was significantly 
down regulated in cells infected with shZFR than in cells 
infected with shCon (p  <  0.01). What’s more, protein 
expression levels of ZFR were also obviously down regu-
lated in cells infected with shZFR than in cells infected 
with shCon. There results suggested shZFR could spe-
cifically and strongly suppress expression of endogenous 
ZFR in pancreatic cancer cells.
Knockdown of ZFR impairs cell viability and colony 
formation
After infection by ZFR shRNA-expressing lentivirus 
for 4 days, we investigated the cell viability for five con-
secutive days by MTT assay. On day 4, compared with 
shCon, the number of viable cells infected with shZFR 
was reduced by 51 % (p < 0.001, Fig. 3a). The reduction in 
growth curve of cells infected with shZFR was more obvi-
ous on day 5, which indicates that shZFR could strongly 
decrease the viability of PANC-1 cells.
In addition, colony formation assay was performed to 
determine cell proliferation in  vitro. Consistently, the 
colony formation was significantly disrupted in cells 
infected with shZFR. As shown in Fig.  3b, the size of 
single colony in cells infected with shZFR was much 
smaller than that in cell infected with shCon, and the 
total number of colonies in 6-well plates was remark-
ably decreased in PANC-1 cells transduced with shZFR, 
in comparison with the control. Specifically, there were 
average 93 colonies in control group, while only aver-
age 11 colonies in shZFR treatment group (p  <  0.001, 
Fig.  3c). These results indicate that shZFR could effi-
ciently inhibit cell viability and proliferation of pancre-
atic cancer cells.
Knockdown of ZFR causes cell cycle arrest
Flow cytometry assay was used to determine the effect 
of shZFR on the cell cycle of PANC-1 cells. Representa-
tive images of cell cycle distribution were presented as 
Fig. 4a. As depicted in Fig. 4b, the cell percentage of G0/
G1 phase was increased from 48.42  % in cells infected 
with shCon to 66.56  % in cells infected with shZFR. 
Meanwhile, the cell percentage of S phase was decreased 
from 26.31 % in control group to 15.91 % in shZFR treat-
ment group, and the cell percentage of G2/M phase was 
decreased from 25.21 to 17.53  %. These results indicate 
that shZFR could strongly arrest PANC-1 cells in the 
G0/G1 phase of the cell cycle (p < 0.001). Moreover, the 
cell percentage of sub-G1 phase, representing cell early 
apoptosis, was increased from 0.09  % in control group 
to 0.81 % in shZFR treatment group (p < 0.001, Fig. 4c). 
Taken together, these results suggest knockdown of ZFR 
could inhibit pancreatic cancer cell proliferation might 
via inducing G0/G1 cell cycle arrest.
Fig. 1 Oncomine studies analysis. The expression of ZFR in pancreatic tumors than pancreas tissues of Badea Pancreas (a) and Segara Pancreas (b)
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Knockdown of ZFR altered cell cycle‑associated proteins 
in PANC‑1 cells
To illuminate the molecular basis for cell cycle arrest caused 
by ZFR knockdown, the expression levels of cell cycle regula-
tory molecular were analyzed by qRT-PCR and Western blot 
analysis. As shown in Fig. 5, knockdown of ZFR significantly 
suppressed the expression levels of CDK2, CDK4, Cyclin A 
and CyclinD1 and enhanced the expression levels of p27 in 
PANC-1 cells. These results suggest that knockdown of ZFR 
in PANC-1 cells leads to cell cycle arrest at G0/G1 phase 
probably via alteration of cell cycle regulatory molecular.
Knockdown of ZFR suppressed cell migration and invasion 
ability in PANC‑1 cells
What’s more, we investigated whether ZFR affected cell 
migration and invasion ability in pancreatic cancer. As 
Fig. 2 Lentivirus stably expressed shRNA targeting ZFR in PANC-1 cells. a Evaluation of the lentivirus transduction rate, which was more than 80 % 
as calculated by cellular enumeration using fluorescence (GFP green fluorescence protein) and light microscopy (Bright). b Quantitative analysis 
of ZFR knockdown efficiency in PANC-1 pancreatic cancer cells assessed by qPCR (β-actin gene was used as an internal control). c Representative 
western blot showing ZFR knockdown efficiency determined in PANC-1 pancreatic cancer cells. GAPDH protein was used as an internal control. 
Data are mean ± S.D. (n = 3; t-test). **p < 0.01; scale bar 100 μm. shCon short hairpin control RNA; sh ZFR short hairpin Zinc finger RNA
Fig. 3 Depletion of ZFR decreases the viability and proliferation of pancreatic cancer cells. a MTT showing growth curves determined in PANC-1 
cells. The number of viable cells was fewer in cells infected with shZFR than in cells infected with shCon. b Representative colony formation show-
ing clonogenic survival determined in PANC-1 cells. c The number of colonies was fewer in cells infected with shZFR than in cells infected with 
shCon. Data are mean ± S.D. (n = 3; t-test). ***p < 0.001; scale bar 250 μm. shCon short hairpin control RNA; sh ZFR short hairpin Zinc finger RNA
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shown in Fig.  6, suppression of ZFR significantly inhib-
ited the migration and invasion of PANC-1 cells, as indi-
cated by a marked decrease in the number of cells that 
invaded the bottom well (p < 0.001).
Discussion
Despite progresses in diagnosis and treatment, pancre-
atic cancer is still considered as the worst prognosis of 
all solid malignant tumors, with a five-year survival of 
less than 5  % [20]. Therefore, a better understanding of 
the molecular mechanisms involved in the progression of 
pancreatic cancer is particularly important for improving 
the treatment efficacy for the pancreatic cancer patients. 
RNA-binding proteins containing the double-stranded 
RNA-binding domain (dsRBD, RBD, or DZF) represent 
a variety of proteins with diverse cellular functions [21]. 
ZFR is a conserved protein with three copies of the C2H2 
zinc finger motif in the N-terminal region and a C-ter-
minal DZF flanked by two nuclear localization signals 
(NLSs). ZFR can be recognized by nuclear factor NF45 
through the DZF-domain, revealing that ZFR may form 
a variety of cellular complexes with other DZF-domain 
proteins, which are involved in a variety of cellular pro-
cesses [22]. Despite most of these proteins are involved 
in the regulation of gene expression, the finger structure 
and functions are not well known.
In this study, we provide new evidence demonstrating 
that ZFR may be a potential tumor marker in human pan-
creatic cancer. ZFR was firstly found to be significantly 
highly expressed in pancreatic tumor tissues compared 
with normal pancreatic tissues by Oncomine database 
analysis. Then we designed shRNAs to specifically block 
its endogenous expression in human pancreatic cell line 
PANC-1 cells. Functional analysis showed knockdown 
Fig. 4 Depletion of ZFR arrests cell cycle progression in pancreatic cancer cells. a Comparison of the cell population in G0/G1, S and G2/M phase 
between shCon and shZFR groups, as assessed by flow cytometry. b The percentage of cells in G0/G1 phase was significantly higher in cells 
infected with shZFR than in cells infected with shCon, while the percentages of cells in S and G2/M phases were simultaneously reduced. c The per-
centage of cells in sub-G1 phase was significantly higher in cells infected with shZFR than in cells infected with shCon. Data are mean ± S.D. (n = 3; 
t-test). **p < 0.01; ***p < 0.001. shCon short hairpin control RNA; sh ZFR short hairpin Zinc finger RNA
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expression of endogenous ZFR significantly decreased 
the viability and invasion ability of PANC-1 cells. Moreo-
ver, FACS analysis showed that knockdown expression of 
ZFR induced a significant cell cycle arrest in the G0/G1 
phase. Cell proliferation proceeds as an orderly progres-
sion through the cell cycle, which is governed by protein 
complexes composed of cyclins and cyclin-dependent 
kinases (cdks) [23]. Besides, CDKs are tightly regulated 
by the association with cyclins. Cyclins and CDKs are 
two kinds of crucial regulatory molecules determining 
cell cycle progression [24]. CDK2, CDK4 and CDK6 are 
activated in association with the D-type Cyclins or Cyclin 
E during G1 progression and G1-S transition [25]. More-
over, sequential activation of the cyclin-CDK complexes 
Fig. 5 Depletion of ZFR suppresses cell cycle-associated proteins in pancreatic cancer cells. Western blot analysis of G0/G1 phase-associated 
proteins in PANC-1 cells after shZFR infection. GAPDH protein was used as an internal control. shCon short hairpin control RNA; sh ZFR short hairpin 
Zinc finger RNA
Fig. 6 Depletion of ZFR inhibited cell migratory and invasive ability in pancreatic cancer cells. a Representative images of migratory cells stained 
with crystal violet. b Quantitative analysis of migratory cell in PANC-1 cells following ZFR knockdown. c Representative images of invasive cells 
stained with crystal violet. d Quantitative analysis of invasive cell in PANC-1 cells following ZFR knockdown. Mean ± standard deviation (SD) of three 
independent experiments. ***p < 0.001 compared with controls
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contributes to the uncontrolled growth which character-
izes cancer. [26]. Herein, we found G0/G1 phase arrest by 
ZFR silencing in PANC-1 cells and compared with that in 
shCon, the expression of CDK2 and CDK4 decreased in 
shZFR infected cells, which suggests knockdown of ZFR 
induces cell arrest through the inhibition of Cyclins and 
CDKs.
Tristetraprolin (TTP or ZFP36), a tandem CCCH zinc 
finger RNA binding protein, has been shown to regu-
late an important subset of cancer-related genes that 
are involved in breast cancer cell growth, invasion and 
metastasis in a 3′UTR- and ARE-dependent manner [27]. 
Therefore, it is likely that ZFR could modulate pancreatic 
cancer growth via the regulation of a subset of cancer-
related genes involved in cellular growth and apoptosis. 
Further investigations are needed to reveal the molecular 
mechanism of the oncogenic function of ZFR in pancre-
atic cancer cells, which would be helpful for early detec-
tion or diagnosis of pancreatic cancer.
In summary, knockdown expression of ZFR by RNAi 
significantly inhibits the growth of PANC-1 cells by 
inducing cell cycle arrest. Our findings provide new evi-
dence that ZFR plays an essential role in cell growth and 
may be a potent therapeutic target in human pancreatic 
cancer, based on which we could develop more effective 
diagnosis approaches for pancreatic cancer to prong the 
patients survival.
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